NUVB
Nuvation BioBNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
NUVB vs peer average
70/100
NUVB vs. peer average (B vs. C)
Grade spread
A 2 · B 1 · C 2 · D 4 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
BHVN is the first available peer comparator.
Biohaven is a closer small/mid-cap biotech commercialization-and-pipeline comparison on risk appetite and catalyst trading, though its asset mix is not directly comparable to ROS1 lung cancer or IDH1 glioma.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NUVB
Nuvation Bio
BHVN
Biohaven
Grade
B
C
Momentum
45
66
Value
41
41
Sentiment
75
63
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs BHVN
NUVB / BHVN
Grade Position
Above peers
NUVB vs. peer average (B vs. C)
70/100
Momentum
45
BHVNValue
41
NUVBSentiment
75
NUVBRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NUVB
BHVN is the first peer returned for this comparison set.